Differential improvement in memory-related task performance with nicotine by aged male and female rhesus monkeys

Behavioural Pharmacology

Volumn 10, Issue 6-7, 1999, Pages 681-690

  Buccafusco, Jerry J ^a   Jackson, W J ^a   Jonnala, R R ^a   Terry Jr , A V ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Aging; Delay matching; Memory; Nicotine; Non human primate; Recall; Sex difference

Indexed keywords

NICOTINE; NICOTINIC RECEPTOR;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE CALCULATION; FEMALE; LATENT PERIOD; MALE; MEMORY; NONHUMAN; RHESUS MONKEY; SEX DIFFERENCE; TASK PERFORMANCE;

EID: 0033372817     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-199911000-00015     Document Type: Article

References (42)

1. Arneric SP, Sullivan JP, Decker MW, Brioni JD, Briggs CA, Donnelly-Robert, D et al. (1994). ABT-418: A novel cholinergic channel activator (ChCA) for the potential treatment of Alzheimer's Disease. In: Alzheimer's Disease Therapeutic Strategies. Giacobini E, Becker R (editors). Boston, MA: Birkhäuser, pp. 196-200.
2. Arneric SP, Sullivan JP, Decker, MW, Brioni JD, Bannon AW, Briggs CA et al. (1995a). Potential treatment of Alzheimer disease using cholinergic channel activators (ChCAs) with cognitive enhancement, anxiolytic-like, and cytoprotective properties. Alzheimer Dis Assoc Disord 9:50-61.
3. Arneric SP, Anderson EJ, Bannon AW, Briggs CA, Buccafusco JJ, Brioni J et al. (1995b). Preclinical pharmacology of ABT-418: A prototypical cholinergic channel activator for the potential treatment of Alzheimer' s disease. CNS Drug Rev 1:1-26.
4. Briggs CA, Anderson DJ, Brioni JD, Buccafusco JJ, Buckley MJ, Campbell JE et al. (1997). Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21. In vitro and in vivo. Pharmacol Biochem Behav 57:231-241.
5. Brioni JD, Decker MW, Sullivan JP, Arneric SP (1997). The parmacology of (-)-nicotine and novel cholinergic channel modulators. Adv Pharmacol 37:153-213.
6. Buccafusco JJ, Jackson WJ (1991). Beneficial effects of nicotine administered prior to a delayed matching-to-sample task in young and aged monkeys. Neurobiol Aging 12:233-238.
7. Buccafusco JJ, Jackson WJ, Terry AV Jr, Marsh KC, Decker MW, Arneric SP (1995a). Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: A novel cholinergic channel activator for memory enhancement. Psychopharmacology 120:256-266.
8. Buccafusco JJ, Jackson WJ, Gattu M, Terry AV Jr (1995b). Isoarecolone-induced memory enhancement in monkeys: Role of nicotinic receptors. NeuroReport 6:1223-1227.
9. Buccafusco JJ, Prendergast M, Terry AV Jr, Jackson WJ (1996). Cognitive effects of nicotinic cholinergic agonists in non-human primates. Drug Dev Res 38:196-203.
10. Chiari A, Eisenach JC (1998). Effects of RJR 2403, a selective nicotinic agonist, in male and female rats. FASEB J 12:A158.
11. Decker MW, Bannon AW, Curzon P, Gunther KL, Brioni JD, Holladay MW et al. (1997). ABT-089 [2-Methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride]: II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeys. J Pharmacol Exp Ther 283:247-258.
12. Elrod K, Buccafusco JJ, Jackson WJ (1988). Nicotine enhances delayed matching-to-sample performance by primates. Life Sci 43:277-287.
13. Faraday MM, Rahman MA, Scheufele PM, Grunberg NE (1998). Nicotine administration impairs sensory gating in Long-Evans rats. Pharmacol Biochem Behav 61:281-289.
14. Farlow MR, Lahiri DK, Poirier J, Davignon J, Schneider L, Hui SL (1998). Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease. Neurology 50:669-667.
15. Filley CM (1997). Alzheimer's disease in women. Am J Obstet Gynecol 176:1-7.
16. Gibbs RB (1998). Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function. Exp Neurol 151:289-302.
17. Gibbs RB, Hashash A, Johnson DA (1997). Effects of estrogen on potassium-stimulated acetylcholine release in the hippocampus and overlying cortex of adult rats. Brain Res 749:143-146.
18. Girdler SS, Jamner LD, Jarvik M, Soles JR, Shapiro (1997). Smoking status and nicotine administration differentially modify hemodynamic stress reactivity in men and women. Psychosom Med 59:294-306.
19. Gritz ER, Nielsen IR, Brooks LA (1996). Smoking cessation and gender: the influence of physiological and psychological, and behavioral factors. J Am Med Womens Assoc 51:35-42.
20. Jackson WJ, Elrod K, Buccafusco JJ (1989). Delayed matching-to-sample in monkeys as a model for learning and memory deficits: Role of brain nicotinic receptors. In: Novel Approaches to the Treatment of Alzheimer's Disease. Meyer EM, Simpkins J, Yamamoto J (editors). New York: Plenum Press, pp. 39-52.
21. Koylu E, Demirgoren S, London ED, Pogun S (1997). Sex differences in up-regulation of nicotinic acetylcholine-receptors in rat-brain. Life Sci 61:PL185-PL190.
22. Levin ED (1992). Nicotinic systems in cognitive function. Pychopharmacology 108:417-431.
23. Macgowan SH, Wilcock GK, Scott M (1998). Effect of gender and apolopprotein E genotype on response to anticholinesterase therapy in Alzheimer's disease. Int J Geriatr Psychol 13:625-630.
24. Mochizuki T, Villemagne VL, Scheffel U, Dannals RF, Finley P, Zhan YG et al. (1998). Nicotine induced tip-regulation of nicotinic receptors in CD-1 mice demonstrated with an in vivo radiotracer: gender differences. Synapse 30:116-118.
25. Newhouse PA, Potter A, Levin ED (1997). Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics. Drugs Aging 11:206-228.
26. Ohkura T, Isse K, Akazawa K, Hamamoto M, Yaoi Y, Hagino N (1994). Low-dose estrogen replacement therapy for Alzheimer-disease in women. Menopause (J North Am Menopause Soc) 1:125-130.
27. Paganinihill A, Henderson VW (1996). Estrogen replacement therapy and risk of Alzheimer-disease. Arch Int Med 156:2213-2217.
28. Paule MG, Bushnell PJ, Maurissen JPJ, Wenger GR, Buccafusco JJ, Chelonis JJ et al. (1998). Symposium overview: the use of delayed matching-to-sample procedures in studies of short-term memory in animals and humans. Neurotoxicol Teratol 20:493-502.
29. Perkins KA, Sexton JE, DiMarco A (1996). Acute thermogenic effects of nicotine and alcohol in healthy male and female smokers. Physiol Behav 60:305-309.
30. Perkins KA, Sanders M, D'Amico D, Wilson A (1997). Nicotine discrimination and sel-administration in humans as a function of smoking status. Psychopharmacology 131:361-370.
31. Prendergast MA, Terry AV Jr, Jackson WJ, Marsh KC, Decker MW, Arneric SP et al. (1997). Improvement in accuracy on a delayed recall task by aged monkeys and mature monkeys after intramuscular or transdermal administration of the CNS nicotinic receptor agonist ABT-418. Psychopharmacology 130:275-284.
32. Prendergast MA, Jackson WJ, Terry AV Jr, Kille NJ, Arneric SP, Buccafusco JJ (1998). Age-related: differences in distractibility and response to methylphenidate in monkeys. Cerebral Cortex 8:164-172.
33. Roberts JA, Gilardi KVK, Lasley B, Rapp PR (1997). Reproductive senescence predicts cognitive decline in aged female monkeys. NeuroReport 8:2047-2051.
34. Rojas NL, Killen JD, Haydel KF, Robinson TN (1998). Nicotine dependence among adolescent smokers. Arch Pediatr Adolesc Med 152:151-156.
35. Schneider LS, Farlow M (1997). Combined tacrine and estrogen replacement therapy in patients with Alzheimer's disease. Ann NY Acad Sci 826:317-322.
36. Sherwin BB (1996). Hormones, mood, and cognitive-functioning in postmenopausal women. Obstetr Gynecol 87:S2-S26.
37. Shieh KR, Pan JT (1996). Sexual differences in the diurnal changes of tuberinfundibular dopaminergic neuron activity in the rat - role of cholinergic control. Biol Reprod 54:987-992.
38. Summers JB, Prendergast MA, Hill WD, Buccafusco JJ (1997). Localization of ubiquitin in the plaques of five aged primates by dual-label fluroescent immunhistochemistry. Alzheimer's Res 3:11-21.
39. Summers JB, Hill WD, Prendergast MA, Buccafusco JJ (1998). Co-localization of apolipoprotein E and beta-amyloid in plaques and cerebral blood vessels of aged non-human primates. Alzheimer's Rep 1:119-128.
40. Terry AV Jr, Buccafusco JJ, Jackson WJ (1993). Scopolamine reversal of nicotine enhanced delayed matching-to-sample performance by monkeys. Pharmacol Biochem Behav 45:925-929.
41. Wenk GL, Pierce DJ, Struble RG, Price DL, Cork LC (1989). Age-related changes in multiple neurotransmitter systems in the monkey brain. Neurobiol Aging 10:11-19.
42. Yilmaz O, Kanit L, Okur BE, Pogun S (1997). Effects of nicotine on active-avoidance learning in rats - sex-differences. Behav Pharmacol 8:253-260.